NAVB
Wells Fargo’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,632
| Closed | -$504 | – | 7349 |
|
|
2023
Q3 | $504 | Buy |
5,632
+140
| +3% | +$13 | ﹤0.01% | 5987 |
|
|
2023
Q2 | $505 | Buy |
5,492
+21
| +0.4% | +$2 | ﹤0.01% | 6177 |
|
|
2023
Q1 | $1.42K | Sell |
5,471
-1,829
| -25% | -$476 | ﹤0.01% | 5970 |
|
|
2022
Q4 | $1.53K | Buy |
7,300
+2,345
| +47% | +$492 | ﹤0.01% | 5745 |
|
|
2022
Q3 | $1K | Buy |
4,955
+1
| +0% | – | ﹤0.01% | 6231 |
|
|
2022
Q2 | $3K | Sell |
4,954
-13
| -0.3% | -$8 | ﹤0.01% | 5975 |
|
|
2022
Q1 | $4K | Sell |
4,967
-19
| -0.4% | -$15 | ﹤0.01% | 6206 |
|
|
2021
Q4 | $5K | Hold |
4,986
| – | – | ﹤0.01% | 6172 |
|
|
2021
Q3 | $8K | Buy |
4,986
+12
| +0.2% | +$19 | ﹤0.01% | 5961 |
|
|
2021
Q2 | $9K | Buy |
4,974
+3
| +0.1% | +$5 | ﹤0.01% | 5862 |
|
|
2021
Q1 | $10K | Buy |
4,971
+30
| +0.6% | +$60 | ﹤0.01% | 5997 |
|
|
2020
Q4 | $10K | Sell |
4,941
-820
| -14% | -$1.66K | ﹤0.01% | 5763 |
|
|
2020
Q3 | $15K | Buy |
5,761
+884
| +18% | +$2.3K | ﹤0.01% | 5519 |
|
|
2020
Q2 | $20K | Sell |
4,877
-3,053
| -38% | -$12.5K | ﹤0.01% | 5398 |
|
|
2020
Q1 | $6K | Buy |
7,930
+136
| +2% | +$103 | ﹤0.01% | 5541 |
|
|
2019
Q4 | $10K | Hold |
7,794
| – | – | ﹤0.01% | 5576 |
|
|
2019
Q3 | $5K | Buy |
7,794
+1,000
| +15% | +$642 | ﹤0.01% | 5662 |
|
|
2019
Q2 | $4K | Sell |
6,794
-89,631
| -93% | -$52.8K | ﹤0.01% | 5663 |
|
|
2019
Q1 | $13K | Hold |
96,425
| – | – | ﹤0.01% | 5494 |
|
|
2018
Q4 | $10K | Hold |
96,425
| – | – | ﹤0.01% | 5562 |
|
|
2018
Q3 | $22K | Buy |
96,425
+300
| +0.3% | +$68 | ﹤0.01% | 5471 |
|
|
2018
Q2 | $22K | Sell |
96,125
-82,340
| -46% | -$18.8K | ﹤0.01% | 5481 |
|
|
2018
Q1 | $65K | Sell |
178,465
-13,896
| -7% | -$5.06K | ﹤0.01% | 5203 |
|
|
2017
Q4 | $69K | Buy |
192,361
+95,922
| +99% | +$34.4K | ﹤0.01% | 5186 |
|
|
2017
Q3 | $40K | Buy |
96,439
+56,439
| +141% | +$23.4K | ﹤0.01% | 5249 |
|
|
2017
Q2 | $20K | Sell |
40,000
-1,000
| -2% | -$500 | ﹤0.01% | 5314 |
|
|
2017
Q1 | $24K | Sell |
41,000
-9,400
| -19% | -$5.5K | ﹤0.01% | 5322 |
|
|
2016
Q4 | $32K | Sell |
50,400
-649
| -1% | -$412 | ﹤0.01% | 5220 |
|
|
2016
Q3 | $47K | Sell |
51,049
-39,500
| -44% | -$36.4K | ﹤0.01% | 5077 |
|
|
2016
Q2 | $48K | Buy |
90,549
+14,338
| +19% | +$7.6K | ﹤0.01% | 5000 |
|
|
2016
Q1 | $73K | Buy |
76,211
+7,979
| +12% | +$7.64K | ﹤0.01% | 4874 |
|
|
2015
Q4 | $91K | Sell |
68,232
-2,963
| -4% | -$3.95K | ﹤0.01% | 4798 |
|
|
2015
Q3 | $162K | Sell |
71,195
-3,577
| -5% | -$8.14K | ﹤0.01% | 4428 |
|
|
2015
Q2 | $121K | Buy |
74,772
+45,947
| +159% | +$74.4K | ﹤0.01% | 4769 |
|
|
2015
Q1 | $45K | Buy |
28,825
+832
| +3% | +$1.3K | ﹤0.01% | 4868 |
|
|
2014
Q4 | $53K | Buy |
27,993
+8,458
| +43% | +$16K | ﹤0.01% | 4812 |
|
|
2014
Q3 | $26K | Sell |
19,535
-3,291
| -14% | -$4.38K | ﹤0.01% | 5041 |
|
|
2014
Q2 | $34K | Buy |
22,826
+11,724
| +106% | +$17.5K | ﹤0.01% | 4987 |
|
|
2014
Q1 | $21K | Buy |
11,102
+300
| +3% | +$567 | ﹤0.01% | 5077 |
|
|
2013
Q4 | $23K | Sell |
10,802
-5,200
| -32% | -$11.1K | ﹤0.01% | 4877 |
|
|
2013
Q3 | $43K | Buy |
16,002
+2,900
| +22% | +$7.79K | ﹤0.01% | 4654 |
|
|
2013
Q2 | $35K | Buy |
+13,102
| New | +$35K | ﹤0.01% | 4633 |
|